{
  "ticker": "OCC",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967666",
  "id": "02967666",
  "pages": 11,
  "price_sensitive": true,
  "date": "20250709",
  "time": "0900",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250709/pdf/06lmlq96pm723l.pdf",
  "summary": "### **Quarterly Report (Appendix 4C) Summary**  \n\n#### **Key Financial & Operational Highlights**  \n- **Revenue**:  \n  - **June 2025 quarter**: **$2.73 million** (up 22.8% QoQ, 45.1% YoY).  \n  - **FY2025 total**: **$9.19 million** (up 35.8% YoY).  \n  - Fifth consecutive quarter of record revenue; **9.5% CQGR** over 3 years.  \n\n- **Cash Position**: **$28.6 million** (no debt), up 38.8% YoY.  \n\n- **US FDA Approval & Rollout (Remplir\u2122)**:  \n  - Cleared for **$1.6bn US nerve repair market** (FDA 510(k) secured April 2025).  \n  - First US surgical use completed; **14 distributors** across 25 states.  \n  - Inventory stockpiled; manufacturing capacity for **100,000 units/year**.  \n\n- **International Expansions**:  \n  - **Remplir\u2122 approved** in Hong Kong, Thailand, and Canada.  \n  - **Striate+\u2122 (dental) approved in Brazil** ($65m market), joining US/EU/UK/SG.  \n\n- **R&D & Clinical Validation**:  \n  - New study confirms Remplir\u2019s superiority over suture-only nerve repair.  \n\n#### **Cash Flow (Appendix 4C)**  \n- **Net operating outflow**: **-$3.54m** (quarter), **-$8.51m** (year).  \n- **Closing cash balance**: **$28.6m** (vs. $31.7m prior quarter).  \n- **Funding runway**: **8.09 quarters** based on current burn rate.  \n\n#### **Material Catalysts Ahead**  \n- **Imminent US sales ramp** for Remplir\u2122 (no revenue yet recorded).  \n- Brazil launch of Striate+\u2122 (1H CY2026).  \n\n---  \n**No other material information identified.**",
  "usage": {
    "prompt_tokens": 7618,
    "completion_tokens": 441,
    "total_tokens": 8059,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-08T23:30:11.688848"
}